PTX3 and atherosclerosis: Several extracellular matrix molecules, besides PTX3, are able to trap FGF2 in the extracellular environment (such as thrombospondin-1 and cleaved syndecan) and modulate its effects during processes such as inflammation, wound healing, atherosclerosis, and neoplasia (70, 71).